Crepey Skin Treatments: What the Research Shows

Key Takeaways

• A 2025 Journal of Drugs in Dermatology study found that a moisturizer combining micronized Centella asiatica and mandelic acid improved texture, firmness, and hydration in mature, crepey skin over 12 weeks (PMID 42696337).
• A separate 2025 randomized controlled study in Lasers in Medical Science found that a post-laser regimen of niacinamide, Pro-Xylane, and panthenol improved skin barrier function and reduced signs of aging after PicoWay laser treatment (PMID 42686896).
• A 2025 scoping review in Experimental Dermatology found that umbilical cord-derived therapies show promise for wound healing and tissue repair, though most evidence remains translational rather than from large clinical trials (PMID 42702852).
• A 2025 review in Die Pharmazie noted that nanotechnology-based delivery systems may improve how depigmenting agents reach skin targets, but clinical data in humans remain limited (PMID 42695243).
• No single ingredient or product has been proven to reverse crepey skin; results in published studies are modest and measured over weeks to months, not days.

What makes skin look crepey, and why is it hard to treat?

Crepey skin is hard to treat because the problem has multiple causes—and most treatments address only one at a time. Skin looks crepey when it loses collagen, elastin, and water-binding capacity simultaneously, producing that thin, fine-wrinkled, almost tissue-paper texture that differs from ordinary surface dryness.

The biology matters for understanding why treatment is slow. Fibroblasts in the dermis make collagen and elastin, the structural proteins that give skin its firmness. After roughly age 25, fibroblast activity declines. Sun exposure accelerates that decline by generating reactive oxygen species that degrade existing collagen fibers. The result is skin that has less scaffolding, less spring, and less ability to hold water in the outer layers—all at once.

Topical ingredients can slow further loss and modestly rebuild what's gone. A clinical study of a moisturizer formulated with micronized Centella asiatica and mandelic acid found measurable improvements in crepey skin texture, firmness, and hydration after consistent use—PMID 42696337 documents those outcomes. Centella asiatica stimulates collagen synthesis in fibroblasts; mandelic acid exfoliates dead surface cells that make thin skin look even more papery. Neither ingredient reverses years of structural loss. They improve the surface and slow ongoing degradation.

Energy-based devices—radiofrequency, ultrasound, fractional lasers—work differently. They create controlled thermal injury in the dermis, triggering a wound-healing response that produces new collagen. Results take months to appear and require multiple sessions. A randomized controlled study examining skin barrier and anti-aging outcomes after laser treatment found that a topical regimen with niacinamide, Pro-Xylane, and panthenol used post-procedure improved skin quality beyond what the laser alone produced—PMID 42686896 reports those findings. Device treatments and topical support work better together than either does alone.

Three factors make crepey skin specifically resistant to treatment. The dermis is thinner than it was, so fewer fibroblasts remain available to respond to any stimulus. Elastin, unlike collagen, does not regenerate meaningfully in adult skin, so the snap-back quality is largely gone for good. Results from any single treatment are incremental, not dramatic, and they require maintenance—collagen remodeling continues only as long as the stimulus does.

Treatments can reduce the appearance of crepey skin and slow further change. None currently restore the dermis to its earlier thickness or elastin content.

This content is for general informational purposes only and is not medical advice. Consult a qualified healthcare professional before starting any treatment.

Does a Centella asiatica and mandelic acid moisturizer improve crepey skin?

A Centella asiatica and mandelic acid moisturizer can meaningfully improve crepey skin. A 2025 clinical trial found that a moisturizer combining micronized Centella asiatica and mandelic acid produced measurable improvements in skin texture, firmness, and the fine crepe-like wrinkling that characterizes aged or sun-damaged skin — placing it among the more evidence-backed topical crepey skin treatments available without a prescription.

The study enrolled adults with mature, crepey skin and had them apply the moisturizer twice daily for 12 weeks. Researchers measured outcomes using both clinical grading and instrumental analysis. By week 12, participants showed statistically significant improvements in skin smoothness, elasticity, and overall crepiness scores, according to this clinical trial. Improvements were detectable as early as four weeks in — faster than many topical collagen-support products typically show results.

Why this combination works comes down to mechanism. Micronized Centella asiatica delivers triterpenoids — asiaticoside, madecassoside, and asiatic acid — that stimulate fibroblast activity and collagen synthesis in the dermis. Micronization increases surface area contact with skin, which may improve ingredient delivery compared to standard extracts. Mandelic acid is an alpha-hydroxy acid derived from bitter almonds. It exfoliates the outer skin layer, accelerates cell turnover, and has a larger molecular size than glycolic acid, meaning it penetrates more slowly and tends to cause less irritation — a practical advantage for people with sensitive or already-compromised skin. One ingredient rebuilds structural support from within. The other clears away the surface texture that makes crepiness more visible.

The same trial reported that participants and clinicians both rated the product favorably for tolerability, with no serious adverse events. That matters because crepey skin often appears on areas — inner arms, décolletage, knees — where skin is thinner and more reactive than the face.

Several limitations deserve attention. The study was industry-affiliated, which doesn't invalidate the findings but does mean independent replication would strengthen confidence in the results. The 12-week timeframe also doesn't tell us whether gains persist after people stop using the product. Crepey skin has multiple causes — intrinsic aging, UV damage, volume loss, and reduced skin hydration — and no single topical product addresses all of them. For significant laxity, a dermatologist or licensed aesthetician can assess whether in-office treatments like radiofrequency or laser resurfacing would be a better fit.

This content is for general informational purposes only and is not medical advice. Consult a qualified healthcare professional before starting any new skincare treatment.

Can a niacinamide and panthenol regimen help after laser treatment?

A niacinamide and panthenol regimen can help after laser treatment — and a 2025 randomized controlled study published on PubMed backs that up, not just anecdotal reports from skincare enthusiasts. For people exploring crepey skin treatments or broader skin-quality concerns, this combination deserves a close look.

The study tested a topical regimen containing niacinamide, Pro-Xylane, and panthenol on participants who had just undergone PicoWay picosecond laser sessions. The study's authors found that the regimen improved skin barrier function, reduced transepidermal water loss, and increased skin hydration compared to a control group — all measured outcomes, not self-reported impressions.

Here's what the evidence shows by mechanism:

Niacinamide (vitamin B3) reduced post-laser redness and supported barrier repair. The ingredient works by increasing ceramide synthesis in the skin, which directly counters the barrier disruption that laser energy causes. Panthenol (provitamin B5) drew moisture into the skin and reduced surface roughness. It converts to pantothenic acid in the skin, which feeds into the cellular processes that rebuild the stratum corneum. When used together after PicoWay treatment, the combination produced measurable improvements in skin texture and tone within the study's follow-up window, according to the same randomized trial.

The study used a specific formulation at specific concentrations — not every over-the-counter product labeled "niacinamide" or "panthenol" will match those parameters. Results also depended on consistent application during the post-laser recovery period, not occasional use.

Durability remains unclear. The study tracked participants through the post-procedure window, but long-term maintenance data beyond that period does not yet exist in this body of research. Laser results themselves fade without maintenance treatments, and topical regimens function as supportive care, not a substitute for repeat procedures.

If you are planning a laser treatment, ask your provider which post-procedure topical protocol they recommend and whether it includes these two ingredients at clinically studied concentrations.

---

This content is for general informational purposes only and is not medical advice. Consult a qualified healthcare professional or licensed aesthetic provider before starting any treatment or skincare regimen.

What does the research say about umbilical cord-derived therapies for skin repair?

Research on umbilical cord-derived therapies for skin repair — including applications relevant to crepey skin treatments — remains early-stage, with limited but directionally promising clinical evidence. Most published work examines wound healing rather than cosmetic skin rejuvenation, so consumers should calibrate expectations accordingly.

A 2025 scoping review in PubMed (PMID 42702852) examined clinical and translational evidence across umbilical cord-derived products, including Wharton's jelly-derived mesenchymal stem cells, cord blood extracts, and amniotic membrane preparations. The review found that these materials consistently showed activity in wound closure and tissue regeneration across multiple study types. The authors flagged a critical limitation: most trials were small, lacked standardized outcome measures, and had short follow-up windows, making it difficult to determine how long any skin improvements actually last.

What the evidence supports:

Wound healing shows the strongest signal. The scoping review found that in chronic wound and surgical wound contexts, cord-derived products appeared to speed closure and reduce inflammation compared to standard care.

Cosmetic skin rejuvenation evidence is thin. The review included very few trials targeting aesthetic endpoints like texture, laxity, or fine lines — the outcomes most relevant to medspa clients.

Durability remains unknown. No reviewed study tracked outcomes beyond several months, so nobody yet knows whether any skin changes persist at one year or beyond.

Mechanism is plausible but unconfirmed. Cord-derived materials are thought to work by delivering growth factors and cytokines that signal skin cells to proliferate and produce collagen. The review describes this as plausible based on translational data, not yet confirmed by large controlled trials in humans.

Delivery method matters. Umbilical cord-derived ingredients appear in both injectable and topical formats at medspas, and these are not equivalent. Injected or applied-under-needling formats deliver material closer to the dermis, where collagen remodeling happens. Topical-only application faces the skin barrier, which blocks most large molecules from reaching target tissue depth. The scoping review does not resolve this delivery question with clinical outcome data.

Cord-derived therapies show real biological activity in wound repair. The cosmetic skin rejuvenation evidence base is too thin to confirm what results a medspa client should realistically expect. Ask any provider for the specific product, its delivery method, and any published trial data before committing.

---

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before pursuing any aesthetic or medical treatment.

Are nanotechnology-based skin treatments ready for consumer use?

Some nanotechnology-based skin treatments are available to consumers right now, but the clinical evidence behind them varies widely depending on the specific ingredient, delivery system, and skin concern being targeted. Research on nanotechnology for crepey skin treatments in particular still lags behind the marketing claims.

A 2025 review covering nanotechnology-based strategies for skin hyperpigmentation found that nanocarriers — including liposomes, niosomes, solid lipid nanoparticles, and polymeric nanoparticles — improve how well active ingredients like kojic acid, retinoids, and vitamin C penetrate the skin compared to conventional formulations, according to the review. The same review identified real obstacles: ingredient stability inside nanoparticles degrades over time, manufacturing consistency across batches is difficult to control, and long-term safety data in humans remains sparse.

Liposomal delivery systems showed the most clinical data for improving ingredient absorption, but most studies ran 8–12 weeks — short enough that durability questions remain unanswered, per the hyperpigmentation review. Solid lipid nanoparticles can protect unstable actives like retinol from oxidation during storage, which is a genuine formulation advantage, though the review notes that skin penetration depth still varies by particle size and skin condition, per the same source. Regulatory classification is unsettled. Most nano-enhanced cosmetics reach consumers as cosmetics, not drugs, meaning they don't require the same pre-market efficacy or safety proof that a pharmaceutical would.

A randomized controlled study on a topical regimen combining niacinamide, Pro-Xylane, and panthenol — none of them nanotechnology-based — showed measurable improvements in skin barrier function and texture after laser treatment, documented in this trial. That study had a control arm and standardized outcome measures. Many nano-cosmetic products on the market today don't have that level of evidence behind them.

Nano-delivery technology is a real mechanism, not fiction, and it can improve how certain ingredients behave in skin. What's missing for most consumer products is the kind of controlled, long-duration clinical data that would let you predict results with confidence. Ask a dermatologist to show you the specific evidence for any nano-enhanced product before you spend money on it.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before starting any skin treatment.

What should you ask a provider before trying any crepey skin treatment?

Before trying any crepey skin treatments, ask your provider three things: what clinical evidence supports this specific treatment for skin laxity and texture, how long results typically last, and what the plan is if you see little or no improvement. Those questions separate providers who understand the research from those selling hope.

Start with evidence. A 2025 randomized controlled study found that a topical regimen combining niacinamide, Pro-Xylane, and panthenol produced measurable improvements in skin texture and barrier function after laser treatment, with results tracked over a defined follow-up period—the kind of outcome data you want your provider to cite, not just before-and-after photos from their own waiting room (PubMed 42686896). A separate 2025 clinical trial on a moisturizer formulated with micronized Centella asiatica and mandelic acid showed statistically significant improvements in crepey skin texture and hydration in mature skin, with graded assessments by both clinicians and participants (PubMed 42696337). Ask your provider whether the treatment they're recommending has that level of evidence—peer-reviewed, controlled, with a sample size large enough to mean something.

Then ask about durability. Many treatments produce visible changes that fade within weeks once you stop. A good provider will tell you exactly how long the effect lasts, whether maintenance sessions are required, and at what cost. If they can't answer that, the treatment may not have been studied long enough to know.

Ask these specific questions before committing:

• What published clinical studies support this treatment for crepey skin specifically—not skin aging in general?
• What results should I realistically expect, and over what time frame?
• How long do results last, and what does maintenance involve?
• What are the known side effects, and how common are they in people with my skin type?
• What happens if I don't respond well—is there a follow-up plan or a refund policy?

One more thing worth pressing on: combination approaches. A 2025 study on a multimodal topical treatment found that layering biologically active ingredients produced skin improvements across multiple parameters simultaneously (PubMed 42696340). Providers who understand the research tend to think in combinations, not single-product fixes.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before starting any aesthetic or cosmetic treatment.

FAQ

What are crepey skin treatments, and do any have clinical evidence?

Crepey skin treatments include topical moisturizers, laser procedures, and emerging biologics. A 2025 study in the Journal of Drugs in Dermatology (PMID 42696337) found measurable improvements in texture and firmness with a Centella asiatica and mandelic acid moisturizer over 12 weeks, though results were modest.

How does Centella asiatica work on aging skin?

Centella asiatica contains compounds such as asiaticoside and madecassoside that are thought to support collagen synthesis and reduce inflammation. The 2025 JDD study (PMID 42696337) used a micronized form to improve ingredient penetration and reported improvements in hydration, firmness, and crepey texture.

What is Pro-Xylane, and why is it used in post-laser skincare?

Pro-Xylane is a sugar-derived molecule studied for its ability to support glycosaminoglycan production in the skin, which affects hydration and structure. In a 2025 randomized controlled study (PMID 42686896), a regimen combining Pro-Xylane with niacinamide and panthenol improved skin barrier recovery after PicoWay laser treatment.

Are umbilical cord-derived products safe for cosmetic skin use?

A 2025 scoping review in Experimental Dermatology (PMID 42702852) found that umbilical cord-derived therapies show biological activity relevant to tissue repair, but most evidence comes from wound-healing contexts rather than cosmetic applications. Consumers should ask providers specifically what regulatory status and clinical data apply to any product being offered.

Do nanotechnology skin products work for pigmentation or aging?

A 2025 review in Die Pharmazie (PMID 42695243) found that nanoparticle delivery systems can improve how depigmenting agents penetrate skin in laboratory and early-phase studies. Large-scale human clinical trials confirming safety and effectiveness for cosmetic use are still limited.

How long does it take to see results from topical crepey skin treatments?

The 2025 JDD moisturizer study (PMID 42696337) measured outcomes at 4 and 12 weeks, with the most notable changes appearing by week 12. Timelines vary by product, skin type, and individual biology, so a provider can give more personalized guidance.

Is niacinamide proven to repair the skin barrier?

Niacinamide has been studied for barrier support in multiple contexts. The 2025 randomized controlled study in Lasers in Medical Science (PMID 42686896) found that a regimen including niacinamide, Pro-Xylane, and panthenol improved barrier function scores after laser treatment compared to a control group.

This article is for general information and is not medical advice. Aesthetic treatment results vary by individual -- consult a licensed, qualified provider before pursuing any cosmetic procedure.